Mycetoma epidemiology, diagnosis management, andoutcome in three hospital centres in Senegal from 2008 to2018

dc.contributor.authorSow, Doudou
dc.contributor.authorNdiaye, Maodo
dc.contributor.authorSarr, Lamine
dc.date.accessioned2023-05-20T21:05:45Z
dc.date.available2023-05-20T21:05:45Z
dc.date.issued2020-04-24
dc.descriptionPloS one, 15(4), e0231871.en_US
dc.description.abstractMycetoma is a neglected tropical disease caused by various actinomycetes or fungi. The disease is characterized by the formationof tumor like-swellings and grains. Senegal is an endemic country where mycetoma cases are under-or misdiagnosed due to thelack of capacities and knowledge among health workers and the community; and where the management of eumycetoma,burdened by a high amputation rate, is currently inadequate. This study aimed to update data on the epidemiology of mycetomacases diagnosed in three hospital centres in Senegal over a 10 years-period. A total of 193 patients, diagnosed from 2008 to 2018,were included in the study. The most frequent presentation was eumycetoma (47.2%); followed by actinomycetoma (36.8%); itremained undetermined in 16.1% of the patients. The mean age was 38.3 years (68.4% of the patients were between 15 and 45years-old); the male: female ratio was a 2.94; and most were farmers. One hundred fifty-six (80.8%) patients had usedphytotherapy before attending the hospital. Mycetoma was mainly located to the lower limbs (91.2%). Grains were observed in 85%of the patients; including white (25.6%) and yellow (4.3%) grains. The etiological diagnosis was complex, resulting in negative directmicroscopy, culture and/or histopathology findings, which explains that 16.1% remained uncharacterized. In most of cases,actinomycetoma were treated with a combination of cotrimoxazole, amoxicillin/clavulanic acid, and streptomycin; whereaseumycetoma cases were treated with terbinafine. The surgery was done in 100 (51.8%) of the patients including 9 inactinomycetoma, 78 in eumycetoma and 13 in undetermined form. The high number of uncharacterized mycetoma in this study, thedelay in attending a qualified health-care facility, and the lack of available adequate antifungal drug, point out the need tostrengthen mycetoma management capacities in Senegal.en_US
dc.description.sponsorshipACEImpact: Environment and Health, CEA-AGIRen_US
dc.identifier.citationSow, D., Ndiaye, M., Sarr, L., Kanté, M. D., Ly, F., Dioussé, P., ... & Faye, B. (2020). Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018. PloS one, 15(4), e0231871.en_US
dc.identifier.urihttps://doi.org/10.1371/journal.pone.0231871
dc.identifier.urihttp://hdl.handle.net/123456789/1817
dc.language.isoenen_US
dc.publisherSow et al.en_US
dc.subjectMamadou D. Kantéen_US
dc.subjectFatoumata Ly, Pauline Diousséen_US
dc.subjectBabacar T. Fayeen_US
dc.subjectAbdou Magip Gayeen_US
dc.subjectCheikh Sokhnaen_US
dc.subjectStéphane Ranqueen_US
dc.subjectBabacar Fayeen_US
dc.titleMycetoma epidemiology, diagnosis management, andoutcome in three hospital centres in Senegal from 2008 to2018en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018 _ PLOS ONE.pdf
Size:
1 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections